Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Clinical presentation of intoxication due to synthetic cannabinoids.

Cohen J, Morrison S, Greenberg J, Saidinejad M.

Pediatrics. 2012 Apr;129(4):e1064-7. doi: 10.1542/peds.2011-1797. Epub 2012 Mar 19.

PMID:
22430444
[PubMed - indexed for MEDLINE]
Free Article
2.

Synthetic cannabinoid use: recognition and management.

Castellanos D, Thornton G.

J Psychiatr Pract. 2012 Mar;18(2):86-93. doi: 10.1097/01.pra.0000413274.09305.9c.

PMID:
22418399
[PubMed - indexed for MEDLINE]
3.

Comparative studies on the effects of the combination drug lorazepam plus diphenhydramine (Somnium) versus lorazepam on the noopsyche, thymopsyche and psychophysiology in nonorganic insomnia related to generalized anxiety disorder.

Grünberger J, Saletu B, Linzmayer L, Böck G, Weissgram S, Brandstaätter N, Frey R, Saletu-Zyhlarz G.

Methods Find Exp Clin Pharmacol. 1997 Nov;19(9):645-54.

PMID:
9500129
[PubMed - indexed for MEDLINE]
4.

Amytal interview using intravenous lorazepam in a patient with dissociative fugue.

Ilechukwu ST, Henry T.

Gen Hosp Psychiatry. 2006 Nov-Dec;28(6):544-5. No abstract available.

PMID:
17088173
[PubMed - indexed for MEDLINE]
5.

[Clinical-experimental testing of the effects of a new hypnotic on respiratory function in healthy subjects and in patients with chronic-obstructive syndrome].

Mühlberger F.

Schweiz Rundsch Med Prax. 1992 Jun 16;81(25):838-40. German.

PMID:
1439406
[PubMed - indexed for MEDLINE]
6.

Driving under the influence of synthetic cannabinoids ("Spice"): a case series.

Musshoff F, Madea B, Kernbach-Wighton G, Bicker W, Kneisel S, Hutter M, Auwärter V.

Int J Legal Med. 2014 Jan;128(1):59-64. doi: 10.1007/s00414-013-0864-1. Epub 2013 May 1.

PMID:
23636569
[PubMed - indexed for MEDLINE]
7.

The "new" marijuana.

Wells DL, Ott CA.

Ann Pharmacother. 2011 Mar;45(3):414-7. doi: 10.1345/aph.1P580. Epub 2011 Feb 15. Review.

PMID:
21325097
[PubMed - indexed for MEDLINE]
8.

Using intravenous diphenhydramine to minimize back pain associated with photodynamic therapy with verteporfin.

Tornambe PE.

Arch Ophthalmol. 2002 Jun;120(6):872. No abstract available.

PMID:
12049608
[PubMed - indexed for MEDLINE]
9.

Synthetic cannabinoid use: a case series of adolescents.

Castellanos D, Singh S, Thornton G, Avila M, Moreno A.

J Adolesc Health. 2011 Oct;49(4):347-9. doi: 10.1016/j.jadohealth.2011.08.002.

PMID:
21939863
[PubMed - indexed for MEDLINE]
10.

Convulsions associated with the use of a synthetic cannabinoid product.

Schneir AB, Baumbacher T.

J Med Toxicol. 2012 Mar;8(1):62-4. doi: 10.1007/s13181-011-0182-2.

PMID:
22160733
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A randomized double-blind placebo-controlled study of low-dose intravenous Lorazepam to reduce procedural pain during bone marrow aspiration and biopsy.

Park SH, Bang SM, Nam E, Cho EK, Shin DB, Lee JH, Ahn JY.

Pain Med. 2008 Mar;9(2):249-52. doi: 10.1111/j.1526-4637.2006.00284.x.

PMID:
18298709
[PubMed - indexed for MEDLINE]
12.

[Model of motion sickness in white mice experiments].

Zhabko EP, Lukomskaia NIa.

Aviakosm Ekolog Med. 1997;31(6):66-8. Russian. No abstract available.

PMID:
9483286
[PubMed - indexed for MEDLINE]
13.

Identifying factors that could account for differences in duration of mechanical ventilation between intermittent lorazepam- and propofol-treated patients.

Devlin JW, Fong JJ, Schumaker GL.

Crit Care Med. 2006 Dec;34(12):3063-4; author reply 3064. No abstract available.

PMID:
17130716
[PubMed - indexed for MEDLINE]
14.

[Symptomatology of chronic and acute marijuana poisoning].

Marmajewska G.

Psychiatr Pol. 1988 Nov-Dec;22(6):474-82. Review. Polish. No abstract available.

PMID:
3077466
[PubMed - indexed for MEDLINE]
15.

Oral risperidone plus oral lorazepam versus standard care with intramuscular conventional neuroleptics in the initial phase of treating individuals with acute psychosis.

Lejeune J, Larmo I, Chrzanowski W, Witte R, Karavatos A, Schreiner A, Lex A, Medori R.

Int Clin Psychopharmacol. 2004 Sep;19(5):259-69.

PMID:
15289699
[PubMed - indexed for MEDLINE]
16.

[Cannabis poisoning in a young child; don't ask about drugs].

de Sonnaville-de Roy van Zuidewijn ML, Schilte PP.

Ned Tijdschr Geneeskd. 1989 Sep 2;133(35):1752-3. Dutch.

PMID:
2797289
[PubMed - indexed for MEDLINE]
17.

Acute intoxication caused by a synthetic cannabinoid in two adolescents.

Heath TS, Burroughs Z, Thompson AJ, Tecklenburg FW.

J Pediatr Pharmacol Ther. 2012 Apr;17(2):177-81. doi: 10.5863/1551-6776-17.2.177.

PMID:
23118671
[PubMed]
Free PMC Article
18.

Interventions for the treatment of acute agitation.

Citrome L.

CNS Spectr. 2007 Aug;12(8 Suppl 11):8-12. Review. No abstract available.

PMID:
19317015
[PubMed - indexed for MEDLINE]
19.

Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.

Saletu B, Saletu-Zyhlarz G, Anderer P, Brandstätter N, Frey R, Gruber G, Klösch G, Mandl M, Grünberger J, Linzmayer L.

Neuropsychobiology. 1997;36(3):130-52.

PMID:
9313245
[PubMed - indexed for MEDLINE]
20.

Organic and synthetic cannabinoid use in adolescents.

Bhatty S, Wu W.

Pediatr Ann. 2013 Jan;42(1):31-5. doi: 10.3928/00904481-20121221-16. No abstract available.

PMID:
23316832
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk